Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?
about
New developments and future opportunities in biomarkers for amyotrophic lateral sclerosisThe role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal modelsElectrophoretic separations of cerebrospinal fluid proteins in clinical investigations.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.Confounding factors influencing amyloid Beta concentration in cerebrospinal fluidBiomarker discovery in neurodegenerative diseases: a proteomic approach.Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseasesClinical proteomics in neurodegenerative disorders.Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal modelsProteomics of human neurodegenerative diseasesAltered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cordProteomic strategies in multiple sclerosis and its animal modelsProteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research.Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A pilot study.Cerebrospinal fluid drainage through the diploic and spinal epidural veins.Cranial arachnoid protrusions and contiguous diploic veins in CSF drainage.Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis 1 / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobankingMulticentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis
P2860
Q26783410-B9656BAB-0ACC-405F-A7B5-11510E3AD324Q28307028-6972F4E5-6D4E-45D7-8059-B2CBBA7A1EFFQ33282300-6AEA4C35-9B22-4F76-9D04-0CF74A42306CQ33467523-EECF64F8-69EB-4A1E-B0DB-374EFCF248AAQ33536646-9C6C92CE-BEEA-4694-B1DB-5A265EC6AEA9Q33731693-32D4A734-4253-4418-960F-BA39EF30429FQ34078408-7AEEE02D-3874-410C-A7D3-A4A00CDBC8B3Q34125681-C5123D91-B24C-42EE-B389-7C57D9847324Q35377133-6CE2A957-F05C-4DD2-9653-773A3EE81DD1Q35880037-8F399571-E3BD-482E-AE00-71C4BD2BD2B2Q36135242-CAF456DA-D587-4B90-A6D6-8A06DDA92908Q36615226-F2451FC1-51E9-45A0-8758-6AFC3FAD499DQ36974613-BD7BE131-E78B-43E6-861D-BF69B6FDDE01Q37086170-8767513A-DB11-468C-8F59-BBA001ABB290Q37248957-5E48E30E-CFC1-430A-A8D3-0C5042D7B868Q37260477-37E85724-84A1-4F8A-83A2-8B593C93B34FQ37276639-2CCB9776-DAB3-4B0A-9CA8-249F4FFCEE07Q37347220-AB97902A-BA60-435A-9FDE-D1650D379B25Q37818319-01F09173-6EB3-453D-8865-046FB59B0804Q38037155-D75E8AC6-BF2B-41D5-9AC8-5776C01004DAQ38063697-17549639-CD94-4795-BF80-92A7A83F549BQ38113846-D4B7F165-3C79-4E3C-8856-C7B23AEC948EQ38207538-3F2C54AE-0D17-4F4E-83D2-3D48D3865C88Q38643847-A168FB9A-37F3-4127-AFE1-02A267D2B55EQ39366291-A076E2F8-648B-4B6E-9407-611447F63805Q42784787-141C2BBC-FA27-4971-92A2-7F97D86BBC3AQ53422343-63018CD1-6C7C-4B98-8231-6C1E5BAA2178Q55058340-A6AF13EB-834D-4EA0-8515-590E5B5909BBQ57267921-D5A64B47-46AA-4210-A923-7DABB8E93D61Q58181716-BC7DF9E0-41E6-4AB0-BF88-81C53CE86ACB
P2860
Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Truncated cystatin C in cerebr ...... rtefact or biological process?
@ast
Truncated cystatin C in cerebr ...... rtefact or biological process?
@en
type
label
Truncated cystatin C in cerebr ...... rtefact or biological process?
@ast
Truncated cystatin C in cerebr ...... rtefact or biological process?
@en
prefLabel
Truncated cystatin C in cerebr ...... rtefact or biological process?
@ast
Truncated cystatin C in cerebr ...... rtefact or biological process?
@en
P2093
P2860
P356
P1433
P1476
Truncated cystatin C in cerebr ...... rtefact or biological process?
@en
P2093
Denis F Hochstrasser
Jean-Charles Sanchez
Odile Carrette
Pierre R Burkhard
Severine Hughes
P2860
P304
P356
10.1002/PMIC.200402039
P577
2005-08-01T00:00:00Z